The physiologic activities concerned with hemostasis and associated with the Factor VIII macromolecular complex were investigated in swine with von Willebrand's disease after infusions of cryoprecipitate, a lyophilized Factor VIII concentrate, or porcine serum. Immediately after each infusion the various activities, antihemophilic factor, von Willebrand platelet aggregating factor, and Factor VIII-related antigen, were elevated in approximate proportion to dose and the bleeding time was shortened. There was a late secondary rise in antihemophilic factor. During the period after infusion, there was a differential fall-off of the various activities, with the bleeding time effect lost first, followed by the von Willebrand platelet aggregating factor and then by the Factor VIIIrelated antigen. The plasma from swine with von Willebrand's disease late after infusion contained high levels of antihemophilic factor without other detectable activities of the complex. Antihemophilic factor, free of the other components, obtained from plasma from swine with von Willebrand's disease either before or late after infusion eluted from agarose gel columns both as high and lower molecular weight material, unlike normal antihemophilic factor, which had a high molecular weight. In contrast, on ultracentrifugation the antihemophilic factor in these plasmas sedimented slowly, even though chromatographically the plasmas contained both high and low molecular weight factor. All of the Factor VIII complex activities in normal porcine plasma sedimented rapidly. These studies demonstrate the heterogeneity of the Factor VIII complex and the apparent dependence of its chromatographic and sedimentation behavior on the functional activities associated with the complex.
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"Factor VIII complex" refers to a macromolecular plasma protein complex that carries several biological functions needed for hemostasis (1) . These functions are concerned with both fibrin clotting and platelet plug formation. Selective functional deficiencies of the Factor VIII complex occur in hemophilia A and in von Willebrand's disease (vWD) . In severe hemophilia, only the antihemophilic factor (AHF) or Factor VIII coagulant activity is lacking. In severe vWD, AHF is greatly reduced or absent, but in addition, the other activities of the Factor VIII complex are lacking. These include: (a) the specific platelet aggregating factor (PAF) or von Willebrand factor (vWF), which in human beings requires ristocetin for its demonstration; (b) the Factor VIII-related antigen, which gives a precipitin reaction with antibody raised to the Factor VIII complex; (c) the bleeding time factor; and (d) a plasma factor, different from AHF, that on transfusion of subjects with vWD causes a delayed rise in AHF.
In normal plasma and plasma concentrates, the AHF of the complex can be dissociated from the PAF/vWF (2) and the Factor VIII-related antigen (3) by an increase in the ionic strength (e.g., 0.25 M CaCd2), followed by gel chromatography.
The isolated AHF is of apparent low molecular weight (4) and 120 hr after infusion. The first four samples were collected from the catheter; thereafter, blood was sampled with an 18-gauge needle. Citrated plasma samples were stored at -70°in 0.5-ml aliquots.
-Assays for Factor VIII Complex Activities. (a) PAF was assayed by a modification of the macroscopic aggregation method of Griggs et al. (9), in which formaldehyde-fixed human platelets prepared by a modification of the method of Allain et al. were used (11) . The test system consisted of 0.2 ml of platelet suspension and 0.1 ml of diluted test materials. The assay was sensitive to <0.05 units/ml of PAF. One unit of PAF is that amount contained in 1 ml of pooled normal porcine plasma. (b) AHF was assayed by a modification of the partial thromboplastin time assay of Langdell and coworkers (9, 12) , using canine hemophilic substrate. The assay was sensitive to <0.0125 unit of AHF per ml (e.g., clotting times: blank >70 sec; 0.0125 unit of AHF per ml, 60 sec). In some.experiments, human hemophilic plasma was used as substrate. Specificity of the assay for AHF was demonstrated by neutralization tests in which two parts test material were mixed with one part diluted plasma from a patient with hemophilia with a high titer of inhibitor. (c) Factor VIII-related antigen was determined by a modification of the quantitative electrophoretic method of Zimmerman et al. (13) . Rabbit antibody against porcine Factor VIII complex was raised by injection of the void volume fraction of the Speywood porcine concentrate. For chromatography, Biogel A--15 m was used (30 X 2.5 cm column at 250, flow of 8 ml/cm2 per hr). Elution was with Tris-buffered saline (0.05 M Tris-HCl, 0.15 M NaCl, pH 7.35). The void volume fraction contained 2.5 units/ml of AHF and 5.5 units/ml of PAF. New Zealand white rabbits were injected with 0.2 ml subcutaneously, then with 0.1 ml at weekly intervals for 3 weeks, and again at 12 and 13 weeks. Blood was collected by cardiac puncture and allowed to clot for 24 hr. The serum was then harvested. Control plasma for this assay as well as for the PAF and AHF assays was from a pool of five normal animals. (d) Saline bleeding times were determined by the method of Mertz (14) .
Chromatographic Studies. Column chromatography was performed with 4% agarose (Biogel A-15 m, 200-400 mesh, Bio-Rad Laboratories, Richmond, Calif). Columns were siliconized glass, 0.9 X 23 cm. Elution buffer was 0.05 M Tris-HC1, pH 7.2. Sample size was 0.5 ml, fractions were collected in 0.5-ml aliquots, and the flow rate was 8 The distribution patterns of AHF on agarose gel chromatography and on sucrose density gradient ultracentrifugation were compared in plasmas collected from pigs with vWD 1, 48, and 120 hr after infusion. Normal porcine plasma and plasma from swine with vWD before infusion similarly studied served as controls. The presence or absence of PAF and Factor-VIIIrelated antigen associated with AHF in the "Factor VIII complex" was also determined. The findings were similar in three separate experiments. The data from one experiment (Exp. 5, Table 1 ) are presented in Fig. 2 .
The behavior of AHF in normal plasma and plasma from swine with vWD before infusion is illustrated in the top two panels of Fig. 2 . The AHF in the normal plasma, which also contained normal amounts of PAF and Factor VIII-related antigen, eluted predominantly in the void volume, and on ultracentrifugation sedimented to the higher density sucrose region near the bottom of the tube. The AHF in the plasma from swine with vWD, which was free of PAF and antigen, was distributed in a biphasic pattern on chromatography; part eluted in the void volume, comparable to AHF in normal plasma, and part eluted in later fractions. In contrast, there was only a single peak of AHF activity on ultracentrifugation; the AHF remained near the top of the tube. Normal plasma, diluted 1:4 with citrated saline to give an AHF level comparable to that in plasma from swine with vWD, was studied in a similar manner. The AHF in the diluted normal plasma was distributed like that in undiluted normal plasma, indicating that the pattern for plasma from swine with vWD was not merely a reflection of low AHF concentration.
In the plasma after infusion, shifting patterns of distribution of AHF were observed, varying with the elapsed time after transfusion and with the presence or absence of associated PAF and Factor VIII-related antigen. In the sample from swine with vWD taken 1 hr after infusion, in which both AHF and PAF were greater than 100%, the chromatographic and ultracentrifugal patterns were similar to those of normal plasma. However, there was some trailing of AHF in late elution volumes on chromatography and in more slowly sedimenting fractions higher in the tube on ultracentrifugation.
In the sample taken 48 hr after infusion, AHF was present in normal amounts but was completely dissociated from the other Factor VIII complex activities. On chromatography, such samples showed a unique pattern of distribution of AHF, different from that in either normal plasma or plasma from swine with vWD plasma. Although the AHF was broadly distributed in all fractions, the void volume gave the highest assay values. On ultracentrifugation, in contrast, the AHF was mainly in the lower density region high in the tube, with samples 6-9 containing the greatest amounts.
In the sample taken 120 hr after infusion, the concentration of AHF was approaching the range before infusion, and its distribution on both chromatography and ultracentrifugation was similar to that of control plasma from swine with vWD.
DISCUSSION
These studies extend earlier findings on the transfusion response of subjects with vWD, human (8, (15) (16) (17) (18) (19) and swine (9, 10, 20, 21 (20) , but not tocorrect the bleeding time. Normal plasma infused in swine (9) 
